跳至主要内容
临床试验/ACTRN12617001086358
ACTRN12617001086358已完成4 期

A prospective pilot study investigating the impact of obesity on seroprotection after influenza vaccination in children aged 9-17 years.

Women's and Children's Hospital0 个研究点目标入组 44 人开始时间: 2017年7月26日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
9 Years 至 17 Years(—)
性别
All

入选标准

  • All participants must satisfy ALL the following criteria at study entry:
  • 1. Participants are healthy children aged between 9-17 years at the time of enrolment.
  • 2. Participants who, in the opinion of the study staff, can and will comply with the requirements of the protocol (eg return for follow-up visits, blood collection).
  • 3. Participants who can provide assent and have a parent willing to provide consent.
  • Additional criteria specific to cases and controls include:
  • Cases - Obese children (BMI >=95th percentile for age and gender) aged 9-17 years. Total number to be enrolled is 25 cases.
  • Controls - Non-obese children (BMI 5th - <95th percentile for age and gender) aged 9-17 years. Total number to be enrolled is 25 controls.

排除标准

  • Presence of any of the following criteria will exclude the subject from receipt of influenza vaccination as part of the study:
  • 1. History of serious medical conditions (eg cardiac, respiratory, renal, hepatic disorders, diabetes mellitus requiring treatment with insulin).
  • 2. Any syndromal and/or endocrinological causes for obesity.
  • 3. History of seasonal influenza vaccination within the last six months prior to enrolment.
  • 4. History of any immunosuppressive condition (eg HIV infection) or on immunosuppressing medication.
  • 5. Any contraindication to influenza immunisation according to the Australian Immunisation Handbook.
  • 6. Anaphylaxis following a previous dose of any influenza vaccine
  • 7. Anaphylaxis following any vaccine component.
  • 8. History of egg allergy.
  • 9. History of Guillain Barre syndrome.
  • 10. Bleeding diathesis or condition associated with prolonged bleeding that may contraindicate intramuscular injection or blood draw.
  • 11. Any major illness that, in the investigator’s judgment, will substantially increase the risk associated with the subject’s participation in the study, or interfere with the evaluation of the study objectives.

研究者

发起方
Women's and Children's Hospital

相似试验

A study on the influence of obesity on the... | 临床试验